Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway

Biochemical and Biophysical Research Communications

Volumn 394, Issue 2, 2010, Pages 317-322

  Tanikawa, Rena ^a   Tanikawa, Takahisa ^a   Hirashima, Mitsuomi ^b   Yamauchi, Akira ^b   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

CD44; Galectin 9; Osteoblast; Smad

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; ECALECTIN; HERMES ANTIGEN; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD44; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; GALECTINS; HUMANS; OSTEOBLASTS; PHOSPHORYLATION; SMAD PROTEINS; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

EID: 77950189165     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.175     Document Type: Article

References (32)

1. Liu F.T., and Rabinovich G.A. Galectins as modulators of tumor progression. Nat. Rev. Cancer 5 (2005) 29-41
2. Rabinovich G.A. Galectins: an evolutionary conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ. 6 (1999) 711-721
3. Barondes S.H., Cooper D.N.W., Git M.A., and Leffler H. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269 (1994) 20807-20810
4. Hirabayashi J., and Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 3 (1993) 297-304
5. Matushita N., Nishi N., Seki M., et al. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J. Biol. Chem. 275 (2000) 8355-8360
6. Hirashima M., Kashio Y., Nishi N., et al. Galectin-9 in physiological and pathological conditions. Glycoconj. J. 19 (2004) 593-600
7. Matsumoto R., Matsumoto H., Seki M., et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 273 (1998) 16976-16984
8. Stock M., Schäfer H., Stricker S., Gros G., Mundolos S., and Otto F. Expression of galectin-3 in skeletal tissue is controlled by Runx2. J. Biol. Chem. 278 (2003) 17360-17367
9. Ortega N., Behonick D., Colnot C., Cooper D.N.W., and Werb Z. Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol. Biol. Cell 16 (2005) 3028-3039
10. Tanikawa R., Tanikawa T., Okada Y., et al. Interaction of galectin-9 with lipid rafts induces osteoblast proliferation through the c-Src/ERK signaling pathway. J. Bone Miner. Res. 23 (2008) 278-286
11. Ghosh-Coundhury N., Harris M.A., Feng J.Q., Mundy G.R., and Harris S.E. Expression of the BMP 2 gene during bone cell differentiation. Crit. Rev. Eukaryot. Gene Expr. 4 (1994) 345-355
12. Hughes F.J., Collyer J., Stanfield M., and Goodman S.A. The effects of bone morphogenetic protein-2, -4, and -6 differentiation of rat osteoblast cells in vitro. Endocrinology 136 (1995) 2671-2677
13. Lee K.-S., Kim H.-J., Li Q.-L., et al. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell Biol. 20 (2000) 8783-8792
14. Komori T., Yagi H., Nomura S., Yamaguchi A., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
15. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998) 753-791
16. Peterson R.S., Andhare R.A., Rousche K.T., et al. CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J. Cell Biol. 166 (2004) 1081-1091
17. Cichy J., and Pure E. The liberation of CD44. J. Cell Biol. 161 (2003) 839-843
18. Bourguignon L.Y.W., Brightman E.G.A., Diedrich F., and Singleton P. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J. Biol. Chem. 281 (2006) 14026-14040
19. Li L., Heldin C.H., and Heldin P. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J. Biol. Chem. 281 (2006) 26512-26519
20. Ito T., Williams J.D., Fraser D., and Philips A.O. Hyaluronan attenuates transforming factor-beta-1-mediated signaling in renal proximal tubular epithelial cells. Am. J. Pathol. 164 (2004) 1979-1988
21. Tanaka Y., Morimoto I., Nakano Y., et al. Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1. J. Bone Miner. Res. 10 (1995) 1462-1469
22. Lowry O.H., Roberts N.R., Wu M., Hixon W.S., and Crawford E.J. The quantitative histochemistry of brain. II. Enzyme measurements. J. Biol. Chem. 207 (1954) 19-37
23. Whyte M.P. Hypophosphatasia: nature's window on alkaline phosphatase function in man. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (1996), Academic Press, San Diego, CA, USA 951-968
24. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Rev. 24 (2003) 218-235
25. Norton J.D. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113 (2000) 3897-3905
26. Ogata T., Wozney J.M., Benezra R., and Noda M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc. Natl. Acad. Sci. USA 90 (1993) 9219-9222
27. Korchynski O., and Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277 (2002) 4883-4891
28. Yamaguchi A., Ishizuya T., Kintou N., and Wada Y. Et al., Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem. Biophys. Res. Commun. 220 (1996) 366-371
29. Jena N., Martin-Seisdedos C., McCue P., and Croce C.M. BMP7 null mutation in mice. Developmental defects in skeleton, kidney, and eye. Exp. Cell Res. 230 (1997) 28-37
30. Kasper M.A.R., Sewnath M.E., Claessen N., et al. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J. Am. Soc. Nephrol. 15 (2004) 674-686
31. Beck JR G.R., Zerler B., and Moran E. Gene array analysis of osteoblast differentiation. Cell Growth & Diff. 12 (2001) 61-83
32. Katoh S., Ishii N., Nobumoto A., et al. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. 176 (2007) 27-35